25 July 2019
Chronic Kidney Disease (CKD) is a heterogenic group of disorders that has a variety of causes and underlying pathologies. As a result, most of the research in CKD is focused on common pathways rather than the causative factors. By studying rare monogenic disorders, it is possible to increase our understanding of the molecular mechanisms involved in common disorders such as CKD.
Recently, we identified mutations in FAM111A in patients with renal failure, short stature, hypoparathyroidism and hypomagnesemia. This syndrome has been first described in the 1960s and has been named Kenny-Caffey syndrome type 2 (KCS2). Although KCS2 has long been considered as an endocrine disorder, our recent findings show that FAM111A mutations cause renal failure and magnesium wasting. In this Dutch Kidney Foundation project proposal, the role of FAM111A will be studied in KCS2 patients to understand how JAK/STAT signaling contributes to renal failure in the general population.
This research project brings together nephrologists, pediatric nephrologists, pathologists and fundamental researchers from Erasmus MC Rotterdam, Radboudumc Nijmegen and a large international network of collaborators. In this team, we aim to link strong research groups specialized in rare disease together with research teams that are focused on common chronic kidney disease. This approach creates a novel research environment that allows knowledge exchange and collaboration between complementary research lines on rare and common diseases.
Chronic Kidney Disease (CKD) is a heterogenic group of disorders that has a variety of causes and underlying pathologies. As a result, most of the research in CKD is focused on common pathways rather than the causative factors. By studying rare monogenic disorders, it is possible to increase our understanding of the molecular mechanisms involved in common disorders such as CKD.
Recently, we identified mutations in FAM111A in patients with renal failure, short stature, hypoparathyroidism and hypomagnesemia. This syndrome has been first described in the 1960s and has been named Kenny-Caffey syndrome type 2 (KCS2). Although KCS2 has long been considered as an endocrine disorder, our recent findings show that FAM111A mutations cause renal failure and magnesium wasting. In this Dutch Kidney Foundation project proposal, the role of FAM111A will be studied in KCS2 patients to understand how JAK/STAT signaling contributes to renal failure in the general population.
This research project brings together nephrologists, pediatric nephrologists, pathologists and fundamental researchers from Erasmus MC Rotterdam, Radboudumc Nijmegen and a large international network of collaborators. In this team, we aim to link strong research groups specialized in rare disease together with research teams that are focused on common chronic kidney disease. This approach creates a novel research environment that allows knowledge exchange and collaboration between complementary research lines on rare and common diseases.
Related news items

Grants for heart and kidney research Two awards to Radboudumc in Open Competition ENW-XS
21 July 2022Two researchers from the Radboudumc receive a grant from the NWO within the Open Competition of the Exact and Natural Sciences. They are Thijs Eijsvogels, who studies the heart, and Pieter Leermakers, who studies the kidneys.
read more
ERC Starting Grant awarded to Jeroen de Baaij
17 March 2022 Jeroen de Baaij, kidney researcher the Radboudumc, receives an ERC Starting Grant worth 1.5 million euros. He will use this grant to improve the diagnosis and treatment of severe magnesium deficiencies, which can lead to epileptic seizures and muscle cramps. read more
Academic collaboration agreement between UTwente and Radboudumc
23 November 2021 The group of Biomaterials Science and Technology (BST) of the Faculty of Science and Technology at the TechMed centre of University of Twente has signed a formal academic collaboration agreement with the departments of Nephrology and Physiology at Radboudumc. read more
Senior Kolff Fellowship for Jeroen de Baaij
29 July 2021 Jeroen de Baaij, theme Renal disorders, received a prestigious Senior Kolff grant from the Dutch Kidney Foundation. His project aims to establish dietary approaches against vascular calcification in chronic kidney disease. read more
Magnesium deficiency increases the risk of cardiovascular disease in diabetic patients
21 June 2021 Publication in Diabetes Care. read more
Lisanne Gommers nominated for James Lind Prize Your vote is needed
25 May 2021Her PhD research entitled "Digesting the role of the gut microbiome in proton pump inhibitor (PPI)-induced hypomagnesemia'' has been nominated for the James Lind Prize. You can vote now until 8 June.
read more